Indian government to crackdown on spurious and substandard drugs

Substandard medicines from India continue to be a major problem, with the number of recalls and alerts for defective prescription drugs reaching a new crescendo, reports The Pharma Letter’s India correspondent.

Though government officials have said the problem is not so much of spurious drugs, but of consistent quality of drugs across the country, the Indian government appears to have decided to crackdown and get to the root of the problem.

As part of a nationwide survey initiated by the Central Drug Standards Control Organization (CDSCO), and to check and verify the quality of medicines sold across the country, nearly 45,000 samples of drugs were tested by random checks.